ANI Pharmaceuticals Inc (ANIP)
65.43
-0.71
(-1.07%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
-0.02
(-0.03%)
After-Hours: 20:00
ANI Pharmaceuticals Free Cash Flow (Quarterly): 39.96M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.96M |
| September 30, 2023 | 27.62M |
| June 30, 2023 | 13.80M |
| March 31, 2023 | 19.07M |
| December 31, 2022 | -7.542M |
| September 30, 2022 | -6.191M |
| June 30, 2022 | -12.80M |
| March 31, 2022 | -21.12M |
| December 31, 2021 | -12.55M |
| September 30, 2021 | -5.985M |
| June 30, 2021 | -21.71M |
| March 31, 2021 | 19.93M |
| December 31, 2020 | -7.828M |
| September 30, 2020 | -7.423M |
| June 30, 2020 | 18.03M |
| March 31, 2020 | -55.84M |
| December 31, 2019 | 3.429M |
| September 30, 2019 | 19.86M |
| June 30, 2019 | 0.786M |
| March 31, 2019 | -5.994M |
| December 31, 2018 | 26.22M |
| September 30, 2018 | 6.947M |
| June 30, 2018 | 2.338M |
| March 31, 2018 | 20.65M |
| December 31, 2017 | -34.31M |
| Date | Value |
|---|---|
| September 30, 2017 | 14.60M |
| June 30, 2017 | -2.303M |
| March 31, 2017 | -46.56M |
| December 31, 2016 | 10.69M |
| September 30, 2016 | -0.005M |
| June 30, 2016 | -57.69M |
| March 31, 2016 | -74.58M |
| December 31, 2015 | 3.597M |
| September 30, 2015 | -16.53M |
| June 30, 2015 | 1.008M |
| March 31, 2015 | -3.492M |
| December 31, 2014 | 10.40M |
| September 30, 2014 | -18.37M |
| June 30, 2014 | 1.701M |
| March 31, 2014 | -7.456M |
| December 31, 2013 | -2.894M |
| September 30, 2013 | -1.665M |
| June 30, 2013 | 3.030M |
| March 31, 2013 | -4.146M |
| December 31, 2012 | -3.247M |
| September 30, 2012 | -7.848M |
| June 30, 2012 | -7.056M |
| March 31, 2012 | -7.744M |
| December 31, 2011 | -11.00M |
| September 30, 2011 | -12.69M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-55.84M
Minimum
Mar 2020
39.96M
Maximum
Dec 2023
0.1839M
Average
-5.985M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -42.68M |
| ADMA Biologics Inc | 16.19M |
| Dentsply Sirona Inc | 120.00M |
| Allogene Therapeutics Inc | -53.89M |
| Vanda Pharmaceuticals Inc | -3.985M |